subgroup of
melanoma)
→
CapableOf
→
progress after anti-ctla-4 treatment
| Typicality: | 0.250 |
| Saliency: | 0.000 |
| advanced melanoma → progress after → anti-ctla-4 treatment | 3 |
| negative | neutral | positive |
| 0.056 | 0.913 | 0.032 |
| Raw frequency | 3 |
| Normalized frequency | 0.000 |
| Modifier score | 0.500 |
| Perplexity | 46.775 |